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Abstract 
Short Communication on t(5;12)(q13;p13) ?/ETV6, 
with data on clinics, and the genes implicated. 
Clinics and pathology 
Disease 
Acute myeloid leukemia (AML) and 
myelodysplastic syndrome (MDS), as well as acute 
lymphoblastic leukemia (ALL) 
Phenotype/cell stem origin 
Five cases are available to date: 3 myeloid cases: an 
AML not otherwise specified, a M2-AML, and a 
RAEB transforming into M2-AML (Kobayashi et 
al., 1994; Yamamoto et al., 2000; Park et al., 2007); 
and 2 lymphoid cases: 2 ALLs (Heinonen et al., 
1988; Sato et al., 1997).  
Is not taken into account in this review a case of 
translocation between 5q13, 12p13, 22q11, and 
3q12 with no possible fusion transcript on any 
derivative chromosome, although ETV6 (12p13) 
and MN1 (22q12), with also sequences on 5q and 
on 3q are implicated in the rearrangements (Belloni 
et al., 2004).  
One case occurred after exposure to mutagenic 
agents: a patient experienced a renal carcinoma 3 
years before onset of the secondary MDS 
(Yamamoto et al., 2000). 
Epidemiology 
The myeloid cases were a 58-year old female 
patient and two 65-year old male patients; the ALL 
cases were a 1-year old girl and a 12-year old girl. 
 
Prognosis 
Scarce data available: a M2-AML case was still 
alive but in relapse 9 months after diagnosis (Park 
et al., 2007), and the MDS case evolved towards a 
M2-AML and the patient died 4 months after 
diagnosis of the MDS (Yamamoto et al., 2000). 
Cytogenetics 
Cytogenetics morphological 
The t(5;12) was the sole anomaly in two myeloid 
cases and part of a complex karyotype in the 
treatment-related myeloid case.  
The t(5;12) was accompanied with a marker 
chromosome in the infant case, and with numerical 
anomalies in the other lymphoid case. 
Genes involved and 
proteins 
Note 
The partner(s) of ETV6 in 5q13 remain(s) 
unknown.  
Both one myeloid and one lymphoid cases were 
tested, and it appears that the breakpoint in ETV6 is 
not identical: the breakpoint was located in intron 1, 
and exon 1 was deleted, in the treatment-related 
myeloid case (Yamamoto et al., 2000), whereas it 
was located 3' of the ETV6 coding sequence in an 
ALL case (Sato et al., 1997). 
ETV6 
Location 
12p13 
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Protein 
452 amino acids. ETV6 is composed of a HLH 
domain responsible for hetero- and 
homodimerization in N-term, and an ETS domain 
responsible for sequence specific DNA-binding in 
C-term (binds to the DNA sequence 5'-
CCGGAAGT-3'). Transcriptional regulator; tumor 
suppressor. Involved in bone marrow 
hematopoiesis. 
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